Detalhe da pesquisa
1.
Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy.
Muscle Nerve
; 65(2): 237-242, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687225
2.
Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial.
Am Heart J
; 166(6): 953-959.e3, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24268208
3.
Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis.
Front Pharmacol
; 14: 1258236, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854715
4.
Efzofitimod: a novel anti-inflammatory agent for sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis
; 40(1): e2023011, 2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975051
5.
Efzofitimod for the Treatment of Pulmonary Sarcoidosis.
Chest
; 163(4): 881-890, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356657
6.
Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre study.
Clin Drug Investig
; 30(5): 313-24, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20384387
7.
Effects of rifampicin (rifampin) on the pharmacokinetics and safety of ambrisentan in healthy subjects: a single-sequence, open-label study.
Clin Drug Investig
; 30(12): 875-885, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20923245
8.
Effect of ketoconazole on the pharmacokinetic profile of ambrisentan.
J Clin Pharmacol
; 49(6): 719-24, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389876
9.
The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers.
Br J Clin Pharmacol
; 67(5): 527-34, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19552747
10.
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease.
Circ Res
; 95(3): 253-60, 2004 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-15217906
11.
Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
Clin Cardiol
; 38(8): 469-75, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26059896
12.
Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials.
J Biomed Mater Res A
; 71(1): 172-80, 2004 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15368267
13.
Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension.
Pulm Circ
; 3(1): 226-44, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23662201